cefoperazone has been researched along with nicardipine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Caracciolo, F; Carulli, G; Grassi, B; Mattii, L; Pardi, C; Petrini, M; Sabbatini, A | 1 |
| Alicea, M; Colucci, RD; Greenstein, R; Halpern, NA | 1 |
| Conte, A; Grassi, B; Mattii, L; Petrini, M; Ronca, G; Sabbatini, AR | 1 |
1 review(s) available for cefoperazone and nicardipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cefoperazone and nicardipine
| Article | Year |
|---|---|
[The pleiotropic drug resistance phenotype: role of reverting agents "in vitro" and "in vivo"].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cefoperazone; Child; Cyclosporine; Doxorubicin; Drug Evaluation; Drug Synergism; Humans; Leukemia; Membrane Glycoproteins; Neoplasm Proteins; Neoplastic Stem Cells; Nicardipine; Phenotype; RNA, Messenger; RNA, Neoplasm; Verapamil | 1991 |
6 other study(ies) available for cefoperazone and nicardipine
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Topics: Ampicillin; Cefoperazone; Chemistry, Pharmaceutical; Drug Incompatibility; Humans; Infusions, Intravenous; Intensive Care Units; Nicardipine; Sulbactam | 1989 |
Activity of different revertant agents on multidrug resistance: in vitro evaluation of their combination.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cefoperazone; Cell Division; Cyclosporine; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Neoplasm Proteins; Nicardipine; RNA, Messenger; Thymidine; Tumor Cells, Cultured | 1993 |